Centre for Cardiovascular Innovation

Centre for Cardiovascular Innovation

The Centre for Cardiovascular Innovation (CCI) is a clinical research operational centre providing services to cardiovascular investigators working in British Columbia to facilitate national and international clinical trials. CCI-CIC is dedicated to improving the health of patients with cardiovascular disease. CCI-CIC provides physical and personnel infrastructure to enhance the research capacity of its member investigators.

CCI-CIC AFFILIATED CENTRES AND PROGRAMS

Transparent. Accountable. Engaged.

CCI-CIC was established by researchers, for researchers.

“The provision to cardiovascular investigators of centralized research personnel, physical infrastructure and institutional expertise will enhance the scope and success of their research. CCI-CIC provides cardiovascular researchers with multiple benefits including cost efficient infrastructure, continuity, and greater autonomy in research planning and conduct. Member investigators of CCI-CIC have strong track records of successful scientific research in all aspects of cardiovascular care and are leaders both nationally and internationally.”

Brady Robinson, CCRP

Brady has been with the UBC/VGH Cardiology Research group since 2014. As a research coordinator, he has worked on a number of both industry and grant funded studies across a wide spectrum of cardiology subspecialties. This experience ranges from local investigator-initiated studies to large international collaborations with sites in Canada, the US, and Europe. In 2019, he obtained certification as a Clinical Research Professional by the Society of Clinical Research Associates, demonstrating a commitment to excellence in clinical trial execution and regulatory compliance under Good Clinical Practice and FDA regulations. Brady has recently joined the CCI-CIC team as the lead clinical research coordinator of the international, multi-site COMPLETE TAVR study.

Jackie Chow

Jackie Chow is a Cardiology Research Manager at VCHRI. Jackie works with the VGH Cardiac Research Team overseeing operations and coordinating studies. She oversee operations and provide leadership to the team. For our clinical trials and registries, she liaises with colleagues, industry and academic institutions. She is also a study coordinator, responsible for ethics applications, enrollment and monitoring patient progress. She is responsible for budget negotiations, account management and financial reports.

Elizabeth Grieve

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Mauris luctus enim quis viverra eleifend. Pellentesque cursus consequat dui ut maximus. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aliquam interdum pharetra tristique. Nullam congue blandit viverra. Sed convallis id urna id scelerisque. Mauris eget mauris eget neque ultrices ultricies. Quisque volutpat suscipit suscipit. Cras aliquam purus lectus, in mollis nibh consectetur sed.

Curabitur eu mauris ac sapien commodo facilisis eget ut turpis. Praesent sit amet nisl in lectus vestibulum vehicula. In eget interdum tellus. Maecenas ullamcorper, odio vitae dictum rhoncus, diam sem feugiat ex, non tempus eros sapien eget urna. In hac habitasse platea dictumst. Phasellus varius interdum lacus, at tincidunt mi pretium ut. Integer ultricies eros nisi, eget vestibulum dolor scelerisque eu.

Current Research Studies

Complete TAVR

Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement.

Automated LVEF

Automated LVEF in Heart Function Clinic: AI-augmented point of care ultrasound. Validating the user of an Artificial Intelligence application to assess image quality and left ventricular ejection fraction in echocardiography, a prospective analysis. Big data and artificial intelligence for risk stratification of patients with COVID-19 symptoms using heart-lung ultrasound.

Point of Care Heart-Lung Imaging

Point of Care heart-lung imaging for patients presenting with COVID-19 symptoms: artificial intelligence precision modeling for prediction of outcomes. Artificial intelligence models for enhancement of LV assessment.

Beyond Atrial Fibrillation

Using Artificial Intelligence, Big Data and Imaging to improve Stroke Risk Assessment and Management. Prevalence and Progression of Tricuspid Regurgitation in Patients with Longstanding Persistent Atrial Fibrillation.

Fabry Disease Screening

Fabry Disease Screening in the Echo Lab: Dried blood spot testing to screen for Fabry disease in patients with increased LV wall thickness identified in the echo lab.

Information Fusion for Echocardiography (INFUSE)

A Novel Platform for Automatic Analysis of Echocardiography Data at Any Point-Of-Care.